Inflammatory markers are poorly predictive of clinical outcomes among hospitalized patients with COVID-19.

ABSTRACT:

Background

Inflammatory markers are often elevated in patients with COVID-19. The objective of this study is to assess the prognostic capability of these tests in predicting clinical outcomes.

Methods

This was a retrospective cohort study including all patients at least 16 years old with COVID-19 who were admitted from one of five Emergency Departments between March 6th and April 4th, 2020. We included 1123 laboratory-confirmed cases of COVID-19. We analyzed white blood cell count (WBC), absolute lymphocyte count (ALC), lactate dehydrogenase (LDH), C-reactive protein (CRP), procalcitonin (PCT), D-dimer, ferritin, and erythrocyte sedimentation rate (ESR). We looked at clinical outcomes including death, the need for endotracheal intubation (ETT), the need for renal replacement

SUBMITTER: Barrett B 

PROVIDER: S-EPMC7685065 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature